INBX
Inhibrx Biosciences, Inc. · Healthcare
CEO Mark Lappe bought $671K of Inhibrx Biosciences, Inc.
Bought$671,150
$15.25Price
44,000Shares
+5%Stake
What INBX did for a copier
- $1,000 copied at Tue, Sep 10 close, $15.18
- $1,041
- S&P 500, same days
- +6.6%
Measured over 30 trading days, to the Oct 22 close.
Mark Lappe's record
5 other buys on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Sep 6. Filed Tue, Sep 10, 1:00 PM ET, during the session. Returns use the Sep 10 close and the Oct 22 close. Not investment advice.